We are live on ! Find out more
CYTH

Cyclo Therapeutics, Inc. Common Stock

Delisted

CYTH was delisted on the 25th of March, 2025.

12 hedge funds and large institutions have $769K invested in Cyclo Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

3% less capital invested

Capital invested by funds: $795K → $769K (-$26K)

8% less funds holding

Funds holding: 1312 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
12
Holders Change
-1
Holders Change %
-7.69%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$490K
Renaissance Technologies
2
Renaissance Technologies
New York
$94K -$32.5K -15,492 -24%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$93K
State Street
4
State Street
Massachusetts
$55K
LPL Financial
5
LPL Financial
California
$19K +$21.1K +10,080 New
TRCT
6
Tower Research Capital (TRC)
New York
$9K +$4.84K +2,310 +102%
Wells Fargo
7
Wells Fargo
California
$4K
BlackRock
8
BlackRock
New York
$1K
IA
9
IFP Advisors
Florida
$1K
Morgan Stanley
10
Morgan Stanley
New York
$1K
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$1K
Osaic Holdings
12
Osaic Holdings
Arizona
$1K +$1.26K +600 New
Citigroup
13
Citigroup
New York
-$2K -1,191 Closed
UBS Group
14
UBS Group
Switzerland
-$2K -793 Closed